YOUNGER patients get Zostavax to prevent shingles

You'll see YOUNGER patients get Zostavax to prevent shingles.

Zostavax was initially approved for ages 60 and the Public Health Agency of Canada recommends it for ages 50 and up.

Zostavax reduces the relative risk of shingles by about 70% for patients age 50 to 59...and by about 50% for patients 60 and up.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote